(Total Views: 402)
Posted On: 04/22/2020 1:18:48 AM
Post# of 30038
Personally, I hope Modi isn't busy, comes back and gets involved.
He's closely tied to COEPTIS & AMBS
COEPTIS
MODI OBOCHI, PHD MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER
High impact and visionary leader with 25+ years of global leadership experience and demonstrated successes leading high performing teams, growing revenues and shareholder value in Pharma and Biotech. Global leadership positions at QLT, Hospira, Pfizer and Baxter spanning general management, commercial, business development and R&D. Expanded Baxter’s $1 billion generic injectable business as the Global VP for Pharmaceuticals Injectables; developed differentiated sterile injectable products for Pfizer; as Head of Global Strategic Marketing at Hospira, accelerated profitable portfolio growth of Hospira’s $3.5 billion sterile injectable pharmaceuticals (including 60 product launches), resulting in the acquisition of Hospira by Pfizer for all cash deal of $15 billion.
Elto Pharma’s transaction with Coeptis Pharmaceuticals, which recently hired Modi Obochi, MD MBA as Chief Executive Officer. Modi brings with him a tremendous pedigree to advance Coeptis’ exciting pipeline of approved and late-stage specialty pharma products
https://www.globenewswire.com/news-release/20...lders.html
Knows LymPro & ELTOPRAZINE
ELTO Pharma & COEPTIS were connected for a bit.
CURE bought COEPTIS and with Dr. Chung at CURE , TODOS and Alzheimer’s Drug Discovery Foundation Modi could come in and do some real heavy lifting!
He's closely tied to COEPTIS & AMBS
COEPTIS
MODI OBOCHI, PHD MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER
High impact and visionary leader with 25+ years of global leadership experience and demonstrated successes leading high performing teams, growing revenues and shareholder value in Pharma and Biotech. Global leadership positions at QLT, Hospira, Pfizer and Baxter spanning general management, commercial, business development and R&D. Expanded Baxter’s $1 billion generic injectable business as the Global VP for Pharmaceuticals Injectables; developed differentiated sterile injectable products for Pfizer; as Head of Global Strategic Marketing at Hospira, accelerated profitable portfolio growth of Hospira’s $3.5 billion sterile injectable pharmaceuticals (including 60 product launches), resulting in the acquisition of Hospira by Pfizer for all cash deal of $15 billion.
Elto Pharma’s transaction with Coeptis Pharmaceuticals, which recently hired Modi Obochi, MD MBA as Chief Executive Officer. Modi brings with him a tremendous pedigree to advance Coeptis’ exciting pipeline of approved and late-stage specialty pharma products
https://www.globenewswire.com/news-release/20...lders.html
Knows LymPro & ELTOPRAZINE
ELTO Pharma & COEPTIS were connected for a bit.
CURE bought COEPTIS and with Dr. Chung at CURE , TODOS and Alzheimer’s Drug Discovery Foundation Modi could come in and do some real heavy lifting!
(0)
(0)Scroll down for more posts ▼
